# TABLOID

NDC: 80725-630
Generic name: thioguanine
Labeler / Manufacturer: Waylis Therapeutics LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230515

FDA application: NDA012429

## Active ingredients

- THIOGUANINE: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"80725-630"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=80725-630
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44b0c461-47fb-4106-ba11-6ed85530235c